Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 Stocks That May Be Trading Below Their Estimated Intrinsic Value

In This Article:

In a week marked by volatility, global markets have been influenced by a mix of corporate earnings reports and geopolitical developments, with U.S. stocks experiencing fluctuations amid AI competition fears and tariff concerns. As investors navigate these complex market conditions, identifying stocks that may be trading below their estimated intrinsic value can offer potential opportunities for those looking to capitalize on discrepancies between market prices and underlying worth.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Wistron (TWSE:3231)

NT$99.00

NT$197.62

49.9%

Alltop Technology (TPEX:3526)

NT$265.00

NT$528.78

49.9%

Decisive Dividend (TSXV:DE)

CA$5.90

CA$11.79

50%

Northwest Bancshares (NasdaqGS:NWBI)

US$13.17

US$26.31

49.9%

Emporiki Eisagogiki Aftokiniton Ditrohon kai Mihanon Thalassis Societe Anonyme (ATSE:MOTO)

€2.72

€5.43

49.9%

Telefonaktiebolaget LM Ericsson (OM:ERIC B)

SEK83.22

SEK165.90

49.8%

Spin Master (TSX:TOY)

CA$30.23

CA$60.17

49.8%

Coastal Financial (NasdaqGS:CCB)

US$86.74

US$172.68

49.8%

Equifax (NYSE:EFX)

US$266.77

US$531.78

49.8%

Facephi Biometria (BME:FACE)

€2.23

€4.45

49.8%

Click here to see the full list of 930 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Kuaishou Technology

Overview: Kuaishou Technology is an investment holding company that offers live streaming, online marketing, and other services in the People’s Republic of China, with a market cap of approximately HK$188.60 billion.

Operations: The company's revenue segments are comprised of Domestic operations generating CN¥119.83 billion and Overseas operations contributing CN¥4.25 billion.

Estimated Discount To Fair Value: 48.9%

Kuaishou Technology is trading at a significant discount to its estimated fair value, with shares priced 48.9% below this benchmark. The company's recent earnings report shows robust growth, with net income rising substantially year-over-year. Despite revenue growth projections being moderate at 8.7% annually, the company is expected to achieve higher profit growth compared to the Hong Kong market average. Recent product innovations and strategic buybacks further enhance its investment appeal based on cash flows.

SEHK:1024 Discounted Cash Flow as at Feb 2025
SEHK:1024 Discounted Cash Flow as at Feb 2025

Galderma Group

Overview: Galderma Group AG is a global dermatology company with a market capitalization of CHF26.90 billion.